We are transforming the incubators of life into cures. Tandem Biotherapeutics Inc. (TBI) is a pre-clinical stage cellular therapy company converting perinatal stem cells and their related cellular products into treatments for a range of severe disorders with unmet clinical needs. Our discoveries and innovations in cell culture processes allow us to leverage the inherent benefits of these cells while enhancing their durability and therapeutic effect on the patient. Our cell therapy platform represents a transformative step in the evolution of safe allogeneic treatments.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tandembio.com
- Keywords
- IT Consulting.
Tandem Biotherapeutics, Inc Questions
Tandem Biotherapeutics, Inc's website is http://www.tandembio.com
Tandem Biotherapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/tandem-biotherapeutics-inc
Tandem Biotherapeutics, Inc has
3 employees.
View email and phone details for 3
employees at Tandem Biotherapeutics, Inc.
Tandem Biotherapeutics, Inc's industry is
Biotechnology Research
Tandem Biotherapeutics, Inc's top competitors are
Albertsons Osco Drug,
Ajinomoto Cambrooke, Inc.,
Acadia Pharmaceuticals Inc.,
Acorn Nmr,
Tessera Therapeutics,
Hahn Imaging Solutions,
Tenaya Therapeutics,
Allworth Diagnostics,
Advasur,
Accessamed.
Tandem Biotherapeutics, Inc's categories are Biotechnology Research
Tandem Biotherapeutics, Inc's founding year is 2002
